BlackRock Institutional Trust’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BFA
BlackRock Institutional Trust's HAE Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Haemonetics (HAE) stake by 3.4% in Q4 2016, buying an estimated $1.66M and bringing the position to 1,328,914 shares worth $53.4M. The position accounts for 0.01% of the portfolio, ranked #1303.
BlackRock Institutional Trust first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.8M in Q1 2015. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.
- BlackRock Institutional Trust held 1,328,914 shares of Haemonetics worth $53.4M as of Q4 2016.
- BlackRock Institutional Trust bought 44,125 Haemonetics shares in Q4 2016, an estimated $1.66M.
- Haemonetics made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1303 holding.
- BlackRock Institutional Trust first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Haemonetics position peaked at $59.8M in Q1 2015.
- 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.